NEW YORK, Nov 7 (Reuters) - Following a shareholder revolt, Dutch publishing giant VNU NV (VNUN.AS: Quote, Profile, Research) is in talks with U.S. pharmaceutical research company IMS Health Inc. (RX.N: Quote, Profile, Research) over how to terminate their $7 billion merger agreement, the Wall Street Journal reported, citing people familiar with the situation.
